OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock

FORT WORTH, Texas, Nov. 5 /PRNewswire-FirstCall/ -- Wound Management
Technologies, Inc., (WNDM), announced today that it has entered into a Letter
of Intent to purchase all healthcare-related assets of Virtual Health
Technologies, Inc. (OTC Bulletin Board: VHGI). The deal provides for VHGI to
be paid $1,000,000 in cash and debt, 4,000,000 shares of WNDM and a royalty
agreement for revenues generated by WNDM on the Veriscrip technology being
acquired from VHGI. WNDM closed at $2.00 per share on 11/4/09 and VHGI
closed at $0.27 per share on 11/4/09.

"WNDM will be acquiring Medical Office Software, Inc. (MOS), Secure eHealth,
LLC, and the Veriscrip technology from Virtual Health Technologies, Inc.,"
stated Scott Haire, CEO of WNDM. "These businesses fit well with WNDM's
domestic plans to leverage its existing infrastructure to develop
opportunities within the Healthcare marketplace, and focus on the U.S.
Government healthcare technology Initiative. We are confident that this will
add tremendously to our bottom line. WNDM will continue to target major
pharmaceutical companies from both a wound care product perspective as well as
a medical technology company, and focus on increasing revenues and maximizing
shareholder value."

"WNDM will be able to significantly expand its product distribution throughout
various medical facilities with the acquisition of an established client base
of approximately 1,500 doctors throughout the US currently using our
technology. In addition many of these physicians have ongoing relationships
with nursing homes which necessitate a need for improved wound care
technology. This acquisition translates into the potential for significant
increased sales for WNDM's core wound care product line," stated Ken Barnes,
President of Medical Office Software.

Debbie Jenkins, Board member of VHGI, states, "As we continue to work with
e-health we realize VHGI's technology plus WNDM's core sales and development
network greatly complement each other, equaling a win for both companies."

The closing of the above transaction will be conditioned among a number of
things, including the execution and delivery of a mutually acceptable
definitive purchase agreement and the approval of the Board of Directors of
both companies as well as the shareholders of VHGI.

For Wound Management Technologies Shareholder Information please call Ronnie
Ambrose at 954-357-0614.

About Wound Management Technologies, Inc.
Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with its
corporate headquarters in Fort Worth, Texas, and regional offices in Ft.
Lauderdale, Florida is a rapidly growing provider of specialty medical
products and advanced biotechnology solutions. The Company is leveraging its
existing technology and infrastructure to develop opportunities within the
International Biotechnology and Genetic Engineering fields. WNDM also
believes it is positioned to develop its technology in Cancer Treatment. For
more information on the Company please visit
www.woundmanagementtechnologies.com or call our shareholder information
department at 954-357-0614.

About VirtualHealth Technologies, Inc.
VirtualHealth Technologies, Inc. is committed to being the leader in the
development and distribution of next generation solutions that connect
healthcare providers to the rest of their community securely and efficiently.
VirtualHealth's foundation is based on years of experience in providing highly
sophisticated technology solutions to its existing medical customers and has
branched out to include the pharmaceutical industry, as well as State and
Federal Regulatory Agencies. VirtualHealth Technologies, Inc. is headquartered
in Lexington, Kentucky, with offices in Texas, Georgia and Florida. For more
information, visit www.virtualhealthtechnologies.com

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of
1995: The statements in the press release that relate to the company's
expectations with regard to the future impact on the company's results from
new products in development are "forward-looking statements," within the
meaning of the Private Securities Litigation Reform Act of 1995. Since this
information may contain statements that involve risk and uncertainties and are
subject to change at any time, the company's actual results may differ
materially from expected results. This document may contain forward-looking
statements concerning the Company's operations, current and future performance
and financial condition. These items involve risks and uncertainties such as
product demand, market and customer acceptance, the effect of economic
conditions, competition, pricing, the ability to consummate and integrate
acquisitions, and other risks and uncertainties detailed in the Company's SEC
filings. The Company undertakes no obligation to revise any of these
statements to reflect the future circumstances or the occurrence of
unanticipated events.

SOURCE Wound Management Technologies, Inc.

Ronnie Ambrose, Shareholder Relations - Communications, +1-954-357-0614